The Active Ingredient Stands Alone
FDA Law Blog: Biosimilars
JULY 11, 2023
To set the stage for this case, we need to go back to March 2020 , when a new definition of “biological product” threw the world of protein products into a tizzy. And, like it has before , the District Court of D.C. recently grappled with this very question in Ipsen v.
Let's personalize your content